Filing Details

Accession Number:
0001193805-13-001518
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-08-23 14:15:49
Reporting Period:
2013-08-15
Filing Date:
2013-08-23
Accepted Time:
2013-08-23 14:15:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1438533 Retrophin Inc. RTRX Pharmaceutical Preparations (2834) 262383102
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1576750 Horacio Plotkin C/O Retrophin, Inc.
777 Third Avenue, 22Nd Floor
New York NY 10017
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-08-15 2,200 $4.50 2,200 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Purchase Warrants Acquisiton 2013-08-15 1,100 $0.00 1,100 $6.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,100 2013-08-15 2018-08-15 No 4 P Direct
Footnotes
  1. On August 15, 2013, in connection with a private placement of the Issuer's securities, the Reporting Person acquired 2,200 shares of the Issuer's common stock, par value $0.0001 per share, at a purchase price of $4.50 per share, and Common Stock Purchase Warrants to purchase up to an aggregate of 1,100 shares of common stock. The aggregate purchase price paid by the Reporting Person in the transaction was $9,900.